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Abstract 
Background: Near-infrared quantum dots (NIR QDs) are a new class of fluorescent labels with excellent bioimaging 
features, such as high fluorescence intensity, good fluorescence stability, sufficient electron density, and strong tissue-
penetrating ability. For all such features, NIR QDs have great potential for early cancer diagnosis, in vivo tumor imaging 
and high resolution electron microscopy studies on cancer cells.
Results: In the present study we constructed NIR QDs functionalized with the NT4 cancer-selective tetrabranched 
peptides (NT4-QDs). We observed specific uptake of NT4-QDs in human cancer cells in in vitro experiments and a 
much higher selective accumulation and retention of targeted QDs at the tumor site, compared to not targeted QDs, 
in a colon cancer mouse model.
Conclusions: NIR QDs labelled with the tetrabranched NT4 peptide have very promising performance for selective 
addressing of tumor cells in vitro and in vivo, proving rising features of NT4-QDs as theranostics.
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Background
Quantum dots (QDs) with unique optical properties 
are a class of novel nanomaterials and have been exten-
sively used in medical research [1, 2]. QDs are nanocrys-
tals with diameters ranging from 2 to 10  nm and when 
coated with water-soluble bioactive material, they form 
core–shell nanostructures that are water soluble and 
biocompatible.
QDs can be conjugated with different molecules, such 
as antibodies or peptides, to obtain target-selective 
functional fluorescent nanodevices with unique opti-
cal properties. These functional QD probes have been 
increasingly used for cell and molecular tracing, in in vivo 
tumor imaging and drug delivery [3, 4].
Near-infrared QDs (NIR QDs) with emission wave-
lengths between 700 and 900  nm have unique optical 
properties, such as high fluorescent intensity and sensi-
tivity, high spatial resolution, excellent fluorescent sta-
bility, deep tissue penetration, minimum photo-damage 
to biological samples and minimum interference from 
background auto-fluorescence by biomolecules in living 
systems [5–8]. In addition QDs have an electron den-
sity compatible with imaging by transmission electron 
microscopy. Therefore NIR QDs have great potential for 
early diagnosis of cancer, in vivo tumor imaging, ex vivo 
ultrastructural studies on tumor cells, and personalized 
tumor therapy [9–11].
In this paper, we report in vitro and in vivo tumor tar-
geting and imaging by NIR QDs functionalized with 
tetra-branched NT4 peptides, which are very promising 
cancer theranostics by virtue of their already established 
high cancer selectivity.
In previous papers, we demonstrated that NT4 very 
selectively binds to human cancer tissues in different 
malignancies and can efficiently and selectively deliver 
drugs or liposomes for cancer cell imaging or therapy, 
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in vitro and in vivo [12–17]. We demonstrated that NT4 
specifically binds to sulfated glycosaminoglycans and 
LRP receptors on cancer cells and tissues. Furthermore, 
NT4 can interfere with cancer cell migration and adhe-
sion and may therefore reduce tumor aggressiveness and 
metastatic potential [18, 19]. We reported that conjuga-
tion of paclitaxel with NT4 leads to increased therapeu-
tic activity of the drug in an orthotopic model of breast 
cancer in mice and produces tumor regression which is 
not achieved with unconjugated paclitaxel under identi-
cal experimental conditions [20].
Results
Conjugation of NIR QDs with NT4
NT4 peptide was conjugated with NIR QDs using com-
mercially available QDs functionalized with amine-
derivatized PEG (Alexa Fluor 705  nm quantum dots, 
Invitrogen). The amine was first conjugated with a 
bifunctional cross-linker, sulfo-SMCC. Then NT4 was 
added to the maleimide double bond via the thiol group 
of the C-terminus cysteine (Scheme 1).
NT4-QDs were purified using superdex 200 by size 
exclusion chromatography. The concentration of puri-
fied NT4-QDs in the eluate was calculated to be 250 nM 
on the basis of the extinction coefficient at 532  nm, 
namely 2.1 × 106/(mol/l)/cm, according to the supplier’s 
instructions.
NMR characterization
To characterize NT4-QDs, NMR spectra of free NT4, 
free QDs and QD-bound NT4 were acquired and com-
pared. In particular, resonances of tyrosine δ- and 
ε-protons were considered because (i) they are the only 
aromatic residues in the NT4/QD system and give sharp, 
intense peaks easy to assign and to follow, (ii) the peak 
intensities of the eight tyrosines from NT4 added up, 
enhancing resolution even at very low concentration 
and were insensitive to pH variations. The free NT4 
one-dimensional proton spectrum showed tyrosine aro-
matics centred at the typical random coil chemical shift 
of 6.95  ppm with little or no differentiation, diagnostic 
of an unstructured peptide (see Fig. 1a). The QD sample 
spectrum showed no resonances at all in the same spec-
tral range (see Fig. 1b), while NT4-QDs showed tyrosine 
peaks, indicating successful binding of the peptide to the 
nanoparticles (see Fig.  1c). Moreover, the aromatic sig-
nals underwent considerable broadening, diagnostic of 
increased correlation time due to slow tumbling of the 
linked nanoparticle. The chemical shift did not change, 
suggesting that no conformational effect was exerted by 
QDs on the peptide. By calibration with the internal TSP 
standard, we estimated an approximate NT4/QD ratio 
of 8:1 (see Additional file 1: Figure S1 for details and full 
NMR spectra).
In‑vitro characterization of NT4‑QDs
NT4-QDs were analysed by transmission electron 
microscopy (TEM) and proved to be well dispersed as 
single particles (Fig. 2a). The hydrodynamic diameter of 
NT4-QDs and QDs was determined by dynamic light 
scattering (DLS) in PBS pH 7.4 and in water at different 
time intervals (time 0 and 24 h). The average size of NT4-
QDs and QDs when tested at 24 h incubation in PBS, was 
17.8 and 19.1  nm, respectively (Fig.  2b and Additional 
file  1: Figure S2). The hydrodynamic diameter did not 
change over time and in different buffers (not shown). 
The fluorescence properties of modified QDs were also 
assessed at 300–800  nm. The fluorescence spectrum 
of equal concentrations of NT4-QDs and QDs showed 
identical peaks of absorption and emission, proving that 
the modification of the QD surface did not impact on the 
fluorescence properties of the final product (Fig. 2c).
Cytotoxicity of NT4-QDs, compared to that of uncon-
jugated QDs, was tested in  vitro in HT-29 human ade-
nocarcinoma cell line (Fig. 2d). NT4-QDs did not show 
any significant cytotoxic activity. At 20  nM, which was 
Scheme 1 Synthesis of NT4-QDs
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the highest concentration of NT4-QDs, slight cytotoxic 
activity was observed after 24 h incubation.
In vitro cell binding of NT4‑QDs
Binding of NT4-QDs was tested in HT29 human colon 
adenocarcinoma cell line by flow cytometry (Fig.  3). 
Cells, incubated with 20  nM NT4-QDs showed a fluo-
rescence signal two log higher than unlabelled QDs and 
the difference proved statistically significant (Fig.  3a; 
p < 0.001). Binding of scalar concentrations of NT4-QDs 
to HT29 cells produced a dose-dependent fluorescent 
signal with very good statistical significance (Fig.  3b). 
Binding of NT4-QDs was inhibited by either unlabelled 
NT4 or heparin, while the much lower signal of unla-
belled QDs was not affected, which confirms the specific-
ity of NT4-QDs cell binding (Fig. 3c–f).
Cell binding and internalization of NT4-QDs were ana-
lysed in HT29 by immunofluorescence (Fig. 4). At time 0 
(binding, detected after 30 min of incubation), NT4-QDs 
(20 nM, red signal) were localized on cell membranes. At 
the following incubation times, NT4-QDs were clearly 
localized intracellularly. No signal was detected with 
unlabelled QDs.
The trafficking of NT4-conjugated particles inside 
the cells was also monitored by TEM (Fig.  5). Particles 
entered the cells by an endocytic-like pathway. A clus-
ter of particles localized on the cell membrane at 30 min 
(Fig. 5a) was then engulfed by vesicles and internalized at 
4 h (Fig. 5b).
In vivo imaging of NT4‑QDs
Athymic nude mice bearing HT29 xenograft tumors 
(2  weeks post inoculation of 1  ×  106  cells, tumor size 
about 0.6–0.8 cm3) were injected with NT4-QDs or unla-
belled QDs (200 pmol of QDs per animal) in the tail vein. 
The mice were imaged at many time points post-injection 
using the Calliper in  vivo imaging system (Fig.  6 and 
Additional file 1: Figure S3).
The excitation filter was set at 585 nm and the emission 
filter at 660 nm to take fluorescence images with a strong 
fluorescent signal and low background signal.
Monitoring of tumor fluorescence intensity showed 
that as early as 0.5 h post-injection, the fluorescent signal 
of NT4-QDs and unlabelled QDs appeared in the tumors 
with higher fluorescent intensity of the latter with respect 
to the former (Fig. 6a).
After 1 h, we detected a higher NIR fluorescent signal 
at the tumor site in mice injected with NT4-QDs than in 
those injected with QDs. At 1 h, nude QDs only showed 
background fluorescence, and the ratio of fluorescent 
Fig. 1 NMR. Region of tyrosine aromatic protons from NMR spectra of (a) free NT4, (b) free QDs and (c) NT4-QDs. Note the absence (b) and pres-
ence of broadened peaks (c) compared to (a)
Page 4 of 10Brunetti et al. J Nanobiotechnol  (2018) 16:21 
Fig. 2 Characterization of NT4-QDs. a TEM image of monodispersed NT4-QDs and unlabelled QDs. Scale bar 50 nm. b Dynamic light scattering of 
NT4-QDs (black line) and QDs (dotted grey line) in PBS buffer after 24 h at 25 °C. The hydrodynamic diameter  (Dh) ± SD and polydispersity index 
(PdI) are reported in the figure. c Fluorescence spectrum of the same concentration (240 nM) of NT4-QDs and unlabelled QDs. d Cytotoxicity of 
NT4-QDs and free QDs in HT29 human colon adenocarcinoma cell line after 24 h incubation at 37 °C
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NT4-QDs:QDs was 318:1 (Fig. 6b), indicating that tumor 
targeting by NT4-QDs induced much higher retention of 
QDs at the tumor site than targeting by nude QDs.
Discussion
Optical imaging in vivo provides real-time tumor visuali-
zation, thus not only allowing diagnosis but also possible 
applications in intraoperative image-guided surgery. Flu-
orescent probes in the near infrared (NIR) have a much 
larger range of in  vivo applications than conventional 
fluorophores because they overcome the problem of tis-
sue autofluorescence.
Quantum dots in the NIR are of great interest for 
in  vivo biological imaging and diagnostics. Compared 
to traditional organic dyes, QDs have the advantage of 
wavelength-tunable emission, broad excitation spec-
tra, sharp fluorescent peak, and high photostability. The 
major problem limiting the use of QDs in human clini-
cal applications is their inherent toxicity, which is influ-
enced by many factors and depends on different types of 
Fig. 3 NT4-QDs binding by flow cytometry. a Flow cytometry analysis showing binding of 20 nM NT4-QDs (light grey) and unlabelled QDs (dark 
grey) to HT29 cells. b Mean fluorescent intensity using different concentrations of NT4-QDs and unlabelled QDs. ***p < 0.001 calculated using one 
tailed Student t test. NT4-QDs (c) and unlabelled QDs (d) binding in the presence of NT4. NT4-QDs (e) and unlabelled QDs (f) binding in the pres-
ence of heparin. Flow cytometric analysis on 10,000 events was done using a BD FACSCanto II instrument (BD, NJ. USA) using a blue laser dye and 
the PerCP-Cy5-5-A channel
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functionalized QDs, their core and shell structures, size 
and surface charge [21, 22].
An important way to minimize QD toxicity is surface 
coating and modification, for example to improve water 
solubility, stability and biocompatibility, or to assign a 
desired bioactivity. For example, coating QDs with hydro-
philic polyethylene glycol (PEG) groups can increase 
stability and reduce aggregation. Coupling QDs with tar-
geting moieties allows more selective tumor uptake and 
retention, thus facilitating detection of tumors and can-
cer cells in vivo and reducing systemic toxicity.
In previous studies we showed that a tetra-branched 
form of neurotensin, called NT4, has extraordinary selec-
tivity towards different human tumors (i.e. colon, pan-
creas and urinary bladder cancer) and is easily coupled 
to chemical entities or liposomes for cancer cell killing or 
imaging [12–17]. In the present study, the tetrabranched 
NT4 peptide was conjugated with NIR QDs function-
alized with amine-derivatized PEG and analysed for 
in vitro and in vivo tumor targeting and imaging. NT4-
QDs were characterized by DLS, NMR analysis, trans-
mission electron microscopy and in  vitro cytotoxicity 
assays, revealing that NT4 conjugation with NIR-QDs 
did not change nanoparticle morphology or aggregation 
state and did not significantly affect cell viability. The 
selective internalization of NT4-QDs and nude QDs in 
tumor cells was analysed by confocal microscopy and 
transmission electron microscopy. In vivo experiments in 
HT29 xenografted mice showed much higher retention 
of NT4-conjugated than unconjugated QDs at the tumor 
site.
The results achieved so far indicate that NT4-labelled 
NIR QDs have very promising performance for selective 
addressing of tumor cells.
Methods
Peptide synthesis
Solid-phase synthesis was carried out on a Mul-
tiSynTech Syro automated multiple peptide syn-
thesizer (Witten, Germany), employing Fmoc 
chemistry with 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetra-
methyluronium hexafluorophosphate/N,N-diisopropyl-
ethylamine (HBTU) activation. NT4-Cys was synthesized 
on Novasyn TGR resin using Fmoc-Cys(Trt)-OH as 
first, and Fmoc-PEG12-OH (Iris Biotech, Germany) as 
second coupling step. Then two coupling steps with 
Fmoc-Lys(Fmoc)-OH were used to build the core. Pyro-
Glu-OPentachlorophenylester was used for the N-ter-
minal acid of the neurotensin sequence. Peptides were 
cleaved from the resins and deprotected by treatment 
with trifluoroacetic acid containing water and triisopro-
pylsilane (95:2.5:2.5) for 1.5 h at room temperature. After 
precipitation with diethyl ether, branched peptides were 
purified by RP-HPLC. Final peptide purity was confirmed 
to be over 99% by HPLC on a C18 Jupiter column (Phe-
nomenex, 300 Å, 5 μm, 250 × 4.6 mm) using 0.1% TFA/
Fig. 4 Binding and internalization (T 1, 2, and 4 h) of NT4 conjugated with NIR QDs (red) on PANC-1 human pancreas adenocarcinoma cells. Nuclei 
are stained with DAPI (blue) and plasma membranes are stained with wheat germ agglutinin Alexa Fluor 488 (green)
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water as eluent A and methanol as eluent B with a linear 
gradient from 80% A to 5% A in 30 min. All peptides were 
characterized by UltraflexIII MALDI TOF/TOF mass 
spectrometry (Bruker Daltonics, Bremen, Germany). 
Commercial reagents, catalysts and ligands were used 
without further purification from freshly opened con-
tainers, unless otherwise stated.
NT4‑QD construction
Qdot 705 ITK amino PEG, used in this study, was com-
mercially available (Qdot 705 ITK™ Amino (PEG) Quan-
tum Dots, Molecular Probes). Amine-modified QDs 
were first conjugated with a bifunctional cross-linker, 
sulfo-SMCC and then with NT4-Cys peptide in the 
molar ratio 1 QDs: 20 linker: 50 peptide. Briefly, QDs 
were exchanged into phosphate buffered saline (PBS, pH 
7.4) by adding 300 μl PBS and concentrating using a PES 
100 K MWCO protein concentrator (Thermo Scientific) 
spun at 3800g at 4  °C. QDs were then conjugated with 
sulfo-SMCC (sulfosuccinimidyl-4-(N-maleimidomethyl)
cyclohexane-1-carboxylate; Thermo Scientific) for 1 h at 
room temperature on a rotator to generate a maleimide-
activated surface on the QDs, and free sulfo-SMCC was 
then removed using a NAP-5 column (GE Healthcare). 
The maleimide-functionalized QDs were incubated with 
NT4-SH for 1  h at room temperature on the rotator. 
10 mM 2-mercaptoethanol was added to the reaction and 
left for an additional 30  min to cap unreacted maleim-
ides. NT4-conjugated QDs were further purified via a 
Superdex 200 column eluting with 20  mM phosphate 
buffer (pH =  7.4). The final concentration of NT4-QDs 
was calculated by detecting absorption at 532 nm using 
Fig. 5 Transmission electron micrographs of HT-29 cell line incubated with NT4-QDs (a, b) or with unlabelled QDs (c). NT4-QD clusters: a localized 
at cell membrane after 30 min of incubation (binding), b entrapped in vesicles inside cells after 4 h of incubation. Scale bar 200 nm
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a spectrophotometer (Jenway, UK) and using the extinc-
tion coefficient 2.1 × 106/(mol/l)/cm as provided by the 
manufacturer. As a control, the absorption of nude QDs 
at the same concentration was measured and the result-
ing difference in absorption at 532 nm between QDs and 
NT4-QDs was + 5% ± 0.6.
NMR analysis
NMR samples of NT4, QDs and NT4/QDs were prepared 
in aqueous PBS pH 7.4 with 10% D2O and a final concen-
tration of 1.25  µM for QDs and NT4/QDs and of 10  µM 
for NT4 (to account for multiple conjugation of peptides 
to QDs). TSP with a concentration of 500 µM was used as 
internal standard. All spectra were acquired on a Bruker 
DRX Avance spectrometer operating at 14.1 Tesla at a tem-
perature of 298 K. One-dimensional spectra were recorded 
by accumulation of 1024 FIDs over 8192 points. The spec-
tral width was set to 6000  Hz and repetition delay to 3  s, 
water suppression was achieved by excitation sculpting [23].
Dynamic light scattering
The size distribution (hydrodynamic diameter; dh) of 
QDs was determined by DLS using a Zetasizer Nano ZS 
from Malvern Instruments. NT4-QDs and QDs were 
diluted in PBS or water at the concentration of 270 nM 
and the hydrodynamic diameter (dh) and the polydisper-
sity index (PdI) were measured at time 0 and after 24 h at 
25 °C. Measures were repeated 20 times.
Fluorescence spectrum
NT4-QDs and QDs were dissolved in PBS at 240 nM and 
the fluorescence spectrum was recorded in a SpectraMax 
M.
Cell cultures
HT29 human colon adenocarcinoma was grown in McCoy’s 
5a Medium supplemented with 10% fetal bovine serum, 
200  µg/ml glutamine, 100  µg/ml streptomycin and 60  µg/
ml penicillin and was maintained in 5%  CO2. Cell lines were 
purchased from ATCC (The Global Bioresource Center).
In vitro cytotoxicity assay
HT29 cells were plated at a density of 5  ×  103/well in 
96-well microplates. Different concentrations, from 0.5 
to 20 nM, of NT4-QDs and undecorated QDs were added 
24 h after plating and cells were incubated for 1 days at 
37 °C. Growth inhibition was assessed by 3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). 
The experiment was performed twice in triplicate. EC50 
values were calculated by non-linear regression analysis 
using Graph Pad Prism 5.03 software.
NT4‑QD binding by flow cytometry
100,000  cells/experiment were incubated in 96-well 
U-bottom plates for 30  min at room temperature with 
different concentrations of NT4-QDs (from 5 to 20 nM) 
in PBS-EDTA 5  mM-BSA 0.5%. Flow cytometric analy-
sis on 10,000 events was done using a BD FACSCanto II 
instrument (BD, NJ. USA) using a blue laser dye and the 
PerCP-Cy5-5-A channel. Assays were performed in trip-
licate and the flow cytometry results were analysed by 
nonlinear regression analysis using GraphPad Prism 5.03 
software.
NT4‑QD binding and internalization
The binding and internalization of NT4-QDs and free 
QDs were tested in HT29 cell line. 3 × 104 cells/well were 
Fig. 6 In vivo NIR fluorescence imaging of HT29 tumor-bearing mice injected with 200 pmol of NT4-QDs (n = 3) and nude QDs (n = 3). ROI 
Fluorescence intensity (a) and tumor-to-background ratio (b) measured at different time intervals in mice injected with NT4-QDs (light grey) or QDs 
(dark grey). The data is represented as mean ± SD. *p < 0.05 compared to mice injected with unconjugated QDs (two-tailed Student’s t test and 
GraphPad Prism 5)
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seeded on 24-well plates, grown for 24 h and then incu-
bated with 20 nM of NT4-QDs or with unlabelled QDs 
for 30 min at 37 °C in PBS-1% BSA. After 30 min of incu-
bation at room temperature, the cells were washed and 
grown in medium for 1, 2 or 4 h at 37 °C to allow peptide 
internalization.
Immunofluorescence
Cells were fixed with PBS 4% formalin and then plasma 
membranes were stained with wheat germ agglutinin-
Alexa Fluor 488 (2.5  µg/ml in PBS-1% BSA). Each step 
was followed by three washes in PBS. Samples, mounted 
using Prolong Gold antifade with DAPI (Molecular 
Probes) were analysed by confocal laser microscope 
(Leica TCS SP5) with 380 λex and 680–750 λem, 380 λex 
and 450–470 λem, and 488 λex and 510–550 λem for NIR 
QDs, DAPI and FITC, respectively. All images were pro-
cessed using ImageJ software (NIH).
Transmission electron microscopy
Analysis of QDs
5  µL of free QDs or NT4-QDs were loaded on carbon 
coated 300 mesh copper grid and after 30 s the excess was 
blotted with filter paper. Samples were analysed with a 
FEI Tecnai G2 SPIRIT transmission electron microscope 
operating at an electron accelerating voltage of 100 kV.
QDs internalization in HT29 cancer cells
Cells were fixed in 2.5% glutaraldehyde solution in phos-
phate buffer 0.1 M pH 7.2 (PB) for 2 h at 4 °C, washed in 
PB, post-fixed in 1%  OsO4 in PB for 30 min at 4 °C, dehy-
drated in an ascending alcohol series, incubated twice 
in propylene oxide and finally infiltrated and embedded 
in epon/araldite resin that was polymerized at 60  °C for 
48 h.
Ultrathin sections  (60  nm) were cut from embedded 
samples on a Reichert-Jung Ultracut E ultramicrotome, 
mounted on 200-mesh copper grids, stained with uranyl 
acetate and lead citrate and observed in a FEI Technai G2 
SPIRIT transmission electron microscope operating at an 
electron accelerating voltage of 100 kV.
In vivo imaging
Athymic female nude mice (Charles River Laboratories, 
Inc.), 5 to 6 weeks of age, were injected s.c. in the flank 
with 1 × 106 HT-29 cells. When tumors reached a diam-
eter of 6–8 mm (2 weeks after tumor inoculation) mice 
were randomly divided into two groups and injected in 
the tail vein with 200 pmol of NT4-QDs and with undec-
orated QDs. Mice were imaged at many time points (0.5, 
1, 3, 5 and 24 h) post-injection using the Calliper in vivo 
imaging system.
All experiments were conducted in accordance with 
the laws and regulations for experiments and procedures 
(Directive 2010/63/EU). All experimentation on live ver-
tebrates described in this article was approved by the Ital-
ian Ministry of Health (Document No. 699/2015-PR).
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